Circulating small non-coding RNA biomarkers of response to triple DMARD therapy in Caucasian women with early rheumatoid arthritis.
CONCLUSION: Pre-treatment levels of specific serum sncRNAs might facilitate identification of patients more likely to respond to triple DMARD therapy.
PMID: 32541082 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Foers AD, Garnham AL, Smyth GK, Proudman SM, Cheng L, Hill AF, Pang KC, Wicks IP Tags: J Rheumatol Source Type: research
More News: Arthritis | Databases & Libraries | Genetics | Hydroxychloroquine | Methotrexate | Rheumatoid Arthritis | Rheumatology | Women